Thus, stimulation of ERK pathway in macrophages appeared to be beneficial for M2-skewing and downmodulation of Th1/17-driven autoimmune inflammation, and vice versa, inhibition of ERK pathway is advantageous for M1 skewing in tumor microenvironment and stimulation of anticancer immunity. Here, MAPK1 is linked to inflammatory response.